A blood-based lipid biomarker panel for personalized risk assessment of breast cancer.

被引：0
|
作者：
Fahrmann, Johannes F. [1 ]
Irajizad, Ehsan [1 ]
Vykoukal, Jody [1 ]
Barrera, Angelica Gutierrez [1 ]
Dennison, Jennifer B. [1 ]
Wu, Ranran [1 ]
Arun, Banu [1 ]
Brewster, Abenaa [1 ]
Hanash, Samir [1 ]
机构：
[1] Univ Texas MD Anderson, Houston, TX USA
来源：
CANCER PREVENTION RESEARCH | 2023年 / 16卷 / 01期
关键词：
D O I：
10.1158/1940-6215.PrecPrev22-P077
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P077
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A Tiny Step Closer to Personalized Risk Prediction for Breast Cancer.
    Devilee, Peter
    Rookus, Matti A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (11): : 1043 - 1045
  • [32] AN INTEGRATED APPROACH TO BLOOD-BASED CANCER DIAGNOSIS AND BIOMARKER DISCOVERY
    Min, Martin Renqiang
    Chowdhury, Salim
    Qi, Yanjun
    Stewart, Alex
    Ostroff, Rachel
    PACIFIC SYMPOSIUM ON BIOCOMPUTING 2014, 2014, : 87 - 98
  • [33] Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort
    Irajizad, Ehsan
    Fahrmann, Johannes F.
    Marsh, Tracey
    Vykoukal, Jody
    Dennison, Jennifer B.
    Long, James P.
    Do, Kim-Anh
    Feng, Ziding
    Hanash, Samir
    Ostrin, Edwin J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (27) : 4360 - +
  • [34] A novel prognostic immunohistochemical biomarker panel for estrogen receptor expressing breast cancer.
    Ross, DT
    Ring, BZ
    Seitz, RS
    Beck, R
    Shasteen, WJ
    Tarr, SM
    Cheang, MC
    Yoder, BJ
    Budd, GT
    Nielsen, TO
    Hicks, DG
    Estopinal, NC
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S124 - S125
  • [35] A novel panel of blood-based microRNAs capable of discrimination between benign breast disease and breast cancer at early stages
    Sadeghi, Hanieh
    Kamal, Aryan
    Ahmadi, Marzieh
    Najafi, Hadi
    Zarchi, Ali Sharifi
    Haddad, Peyman
    Shayestehpour, Bahareh
    Kamkar, Leila
    Salamati, Masoumeh
    Geranpayeh, Loabat
    Lashkari, Marzieh
    Totonchi, Mehdi
    RNA BIOLOGY, 2021, 18 : 747 - 756
  • [36] A blood-based biomarker for checkpoint inhibition
    Hannah Stower
    Nature Medicine, 2018, 24 (12) : 1781 - 1781
  • [37] Calretinin as a blood-based biomarker for mesothelioma
    Johnen, Georg
    Gawrych, Katarzyna
    Raiko, Irina
    Casjens, Swaantje
    Pesch, Beate
    Weber, Daniel G.
    Taeger, Dirk
    Lehnert, Martin
    Kollmeier, Jens
    Bauer, Torsten
    Musk, Arthur W.
    Robinson, Bruce W. S.
    Bruening, Thomas
    Creaney, Jenette
    BMC CANCER, 2017, 17
  • [38] Potential of blood-based biomarker approaches in endometrium and breast cancer: a case-control comparison study
    Schuhn, Anne
    Tobar, Tania Witte
    Gahlawat, Aoife Ward
    Hauke, Jana
    Baumann, Lukas
    Okun, Juergen G.
    Nees, Juliane
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 306 (05) : 1623 - 1632
  • [39] Calretinin as a blood-based biomarker for mesothelioma
    Georg Johnen
    Katarzyna Gawrych
    Irina Raiko
    Swaantje Casjens
    Beate Pesch
    Daniel G. Weber
    Dirk Taeger
    Martin Lehnert
    Jens Kollmeier
    Torsten Bauer
    Arthur W. Musk
    Bruce W. S. Robinson
    Thomas Brüning
    Jenette Creaney
    BMC Cancer, 17
  • [40] A blood-based prognostic biomarker in IBD
    Biasci, Daniele
    Lee, James C.
    Noor, Nurulamin M.
    Pombal, Diana R.
    Hou, Monica
    Lewis, Nina
    Ahmad, Tariq
    Hart, Ailsa
    Parkes, Miles
    McKinney, Eoin F.
    Lyons, Paul A.
    Smith, Kenneth G. C.
    GUT, 2019, 68 (08) : 1386 - 1395
12345